Follow
Tumor
Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.
What's Popular in Tumor
-
OCT 14, 2025Drug Discovery & Development
A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast can ...Written By: Annie LennonAUG 29, 2025eBooksDownload your copy of "Enable precision medicine with comprehensive genomic profiling CGP" eBook to learn more ...JUL 17, 2025Cannabis Sciences
New research has found a link between cannabis use disorder (CUD) and benign salivary gland tumors.Written By: Annie LennonJUN 27, 2025Clinical & Molecular DX
When tumors grow, they can shed DNA that is detectable in the blood.Written By: Carmen LeitchMAY 26, 2025Clinical & Molecular DX
Scientists have developed a rapid test that uses genetic tools to diagnose brain tumors. This method can reduce the diag ...Written By: Carmen Leitch
OCT 14, 2025
Drug Discovery & Development
A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast can
...
Written By:
Annie Lennon
AUG 29, 2025
eBooks
Download your copy of "Enable precision medicine with comprehensive genomic profiling CGP" eBook to learn more
...
JUL 17, 2025
Cannabis Sciences
New research has found a link between cannabis use disorder (CUD) and benign salivary gland tumors.
Written By:
Annie Lennon
JUN 27, 2025
Clinical & Molecular DX
When tumors grow, they can shed DNA that is detectable in the blood.
Written By:
Carmen Leitch
MAY 26, 2025
Clinical & Molecular DX
Scientists have developed a rapid test that uses genetic tools to diagnose brain tumors. This method can reduce the diag
...
Written By:
Carmen Leitch
MAY 19, 2025
Cell & Molecular Biology
Pancreatic cancer is deadly; only about 10% of patents live over five years after they are diagnosed. Patients are typic
...
Written By:
Carmen Leitch
APR 23, 2025
Microbiology
There are trillions of microbes in the gastrointestinal tract, and we are starting to learn more about the exact mechani
...
Written By:
Carmen Leitch
APR 22, 2025
Clinical & Molecular DX
When a tumor starts to grow in the body, small bits of its genetic material may break away and float off into the bloods
...
Written By:
Carmen Leitch
APR 06, 2025
Genetics & Genomics
There is plenty of evidence to show that smoking cigarettes increases the risk of cancer and other health problems, and
...
Written By:
Carmen Leitch
-
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...MAR 26, 2024 | 7:00 PMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificMAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...MAR 26, 2024 | 8:00 AMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher Scientific
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MAR 21, 2024 | 10:00 AM
Next-generation sequencing (NGS) based liquid biopsy is emerging as standard of care in oncology for comprehensive genomic profiling (CGP) of solid tumors. In this presentation we will showc...
MAR 20, 2024 | 8:00 AM
Deciphering somatic mosaicism in healthy tissues and clonal diversity in tumors necessitates single-cell analysis. High-quality genomic and transcriptomic data at the single-cell level depen...
MAR 13, 2024 | 8:00 AM
Our presenter Jonathan Nowak, will discuss representative multiplexed assays for protein and RNA profiling built in the lab and discuss the necessary elements to operationalize this type of...
FEB 29, 2024 | 3:00 PM
C.E. CREDITS
In recent years, small volume biopsies have been increasingly utilized for diagnosis of tumors in both primary and recurrent settings. Concomitantly, the numbers of ancillary studies for cha...
-
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...OCT 01, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...APR 30, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...OCT 02, 2024 | 7:00 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
APR 30, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...
OCT 02, 2024
| 7:00 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
APR 30, 2024
| 5:00 AM PDT
C.E. CREDITS
LabRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on May 1, 2024. Immuno-Oncology is considered by some to be one of the most promising area...
FEB 29, 2024
| 12:00 PM PST
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
JAN 31, 2024
| 7:00 AM PST
This half-day virtual event welcomes industry scientists, government employees, and academic researchers interested in exploring the quickly evolving world of epigenetics! This 4-hr event, o...
OCT 03, 2023
| 5:30 AM PDT
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....